Zhengye Biotechnology Holding (ZYBT) Total Liabilities (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Total Liabilities data on file, last reported at $18.3 million in Q4 2025.

• Total Liabilities for Q4 2025 came in at $18.3 million, down 6.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $18.3 million (down 6.61% YoY), and the FY2025 annual result was $18.6 million, down 3.72% from the prior year.
• Total Liabilities retreated to $18.3 million in Q4 2025 per ZYBT's latest filing, from $19.5 million in the prior quarter.
• Over five years, Total Liabilities peaked at $22.3 million in Q4 2023 and troughed at $18.3 million in Q4 2025.
• A 3-year average of $19.9 million and a median of $19.5 million in 2024 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities decreased 12.19% in 2024, then declined 6.61% in 2025.
• A 3-year view of Total Liabilities shows it stood at $22.3 million in 2023, then declined by 12.19% to $19.6 million in 2024, then slipped by 6.61% to $18.3 million in 2025.
• Business Quant data shows ZYBT's Total Liabilities at $18.3 million in Q4 2025, $19.5 million in Q2 2025, and $19.6 million in Q4 2024.